| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.17 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |